Portfolio company
Green Park Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops stable liquid formulations of existing medicines for patients who have difficulty swallowing traditional tablets and capsules.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Disruptive Pharma
This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.
Neurocentrx Pharma Ltd
This biopharmaceutical company develops oral ketamine formulations to treat patients suffering from treatment-resistant mood disorders, neurodegenerative diseases, and complex pain conditions.
Spherics
This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.
Emulsi Biotech
Emulsi Biotech develops lipid-based oral drug delivery platforms to enable pharmaceutical companies to administer complex biological therapies through capsules instead of injections.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
AcousticaBio
The company develops fluid processing technology to formulate medicines into high-concentration subcutaneous injections for biopharmaceutical firms and healthcare providers.
Pharmasum Therapeutics
This company develops neurological drugs for patients with dementia, Alzheimer's disease and Down syndrome to provide to the global healthcare market.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.